Intech Biopharm Ltd (6461) — Financial Flexibility Index
Intech Biopharm Ltd (6461) has a Financial Flexibility Index of -0.04x as of December 2025. Free cash flow of NT$-54.56 Million (operating CF NT$-64.39 Million minus capex NT$9.84 Million) represents 0% of total liabilities (NT$1.25 Billion). Also explore Intech Biopharm Ltd annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Intech Biopharm Ltd Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Intech Biopharm Ltd across 9 annual periods. Check asset allocation strategy of Intech Biopharm Ltd to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Intech Biopharm Ltd (2017–2025)
Year-by-year free cash flow to debt coverage for Intech Biopharm Ltd. For the full company profile including market capitalisation, see Intech Biopharm Ltd (6461) total market value.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.24x | NT$-297.12 Million | NT$-361.13 Million | NT$1.25 Billion | ▼ -66.6% |
| 2024 | -0.14x | NT$-225.59 Million | NT$-269.22 Million | NT$1.58 Billion | ▼ -26.6% |
| 2023 | -0.11x | NT$-173.93 Million | NT$-204.13 Million | NT$1.54 Billion | ▲ +4.6% |
| 2022 | -0.12x | NT$-179.39 Million | NT$-190.39 Million | NT$1.52 Billion | ▲ +16.7% |
| 2021 | -0.14x | NT$-179.30 Million | NT$-200.61 Million | NT$1.26 Billion | ▼ -53.8% |
| 2020 | -0.09x | NT$-119.22 Million | NT$-167.38 Million | NT$1.29 Billion | ▲ +30.6% |
| 2019 | -0.13x | NT$-137.79 Million | NT$-189.09 Million | NT$1.04 Billion | ▼ -379.3% |
| 2018 | -0.03x | NT$-28.41 Million | NT$-232.43 Million | NT$1.02 Billion | ▼ -121.8% |
| 2017 | 0.13x | NT$112.97 Million | NT$-145.29 Million | NT$887.48 Million | — |